Sarfati
Daniel Sarfati, Raanana IL
Patent application number | Description | Published |
---|---|---|
20140173105 | MANAGEMENT OF INFORMATION-TECHNOLOGY SERVICES - A system includes a collection module configured to collect data characterizing usage of a plurality of software applications hosted on a network by users of a set of client devices, a data-storing module configured to store the collected data, and a processing module configured to determine, based on the stored data, at least one usage metric for each of the plurality of software applications. | 06-19-2014 |
Eric Sarfati, Toulon FR
Patent application number | Description | Published |
---|---|---|
20100185137 | DEVICE FOR TREATMENT OF WATERING OF THE EYE - The present invention relates to a device ( | 07-22-2010 |
Gadi Sarfati, Kibbutz Beit Guvrin IL
Patent application number | Description | Published |
---|---|---|
20140018386 | LAQUINIMOD FORMULATIONS WITHOUT ALKALIZING AGENT - The subject invention provides a stable pharmaceutical composition comprising a therapeutically effective amount of laquinimod, an amount of a filler, and an amount of a lubricant, wherein the stable pharmaceutical composition is free of an alkalizing agent or an oxidation reducing agent. Also provided are processes for making the stable pharmaceutical composition and sealed packages comprising the stable pharmaceutical composition. Also provided is a method for treating a subject afflicted with a form of multiple sclerosis (MS) or for alleviating a symptom of MS in a subject afflicted with a form of MS comprising administering to the subject a stable pharmaceutical composition as described herein. Also provided is use of a stable pharmaceutical composition as described herein for treating a subject afflicted with a form of MS or for alleviating a symptom of MS in a subject afflicted with a form of multiple MS. | 01-16-2014 |
Marie Sarfati, Montreal CA
Patent application number | Description | Published |
---|---|---|
20110237498 | SOLUBLE POLYPEPTIDES FOR USE IN TREATING AUTOIMMUNE AND INFLAMMATORY DISORDERS - The present invention relates to soluble CD47 binding polypeptides, for use as a medicament, in particular for the prevention or treatment of autoimmune and inflammatory disorders, for example allergic asthma and inflammatory bowel diseases. The invention more specifically relates to a soluble CD47 binding polypeptide for use as a medicament, comprising an extracellular domain of SIRPα (CD172a) or functional derivatives which bind to human CD47. | 09-29-2011 |
20130011401 | SOLUBLE PROTEINS FOR USE AS THERAPEUTICS - The present invention relates to soluble SIRPα binding proteins, for use as a medicament, in particular for the prevention or treatment of autoimmune and inflammatory disorders, for example allergic asthma and inflammatory bowel diseases. The invention more specifically relates to a soluble SIRPα binding protein comprising a complex of two heterodimers, wherein each heterodimer essentially consists of: | 01-10-2013 |
Patrice Sarfati, Garches FR
Patent application number | Description | Published |
---|---|---|
20140287418 | COMPOSITION FOR AMPLIFYING NUCLEIC ACIDS - The invention relates to a concentrated and buffered liquid composition for amplifying nucleic acids, comprising at least one dNTP, at least one enzyme required for the amplification, at least one oligonucleotide primer, and at least one fluorescent nucleotide probe, in the presence of a polyol and/or of polyvinylpyrrolidone (PVP). | 09-25-2014 |